Pulsetto’s innovation takes on a new mission: supporting soldiers’ resilience
Supporting soldiers and frontline personnel in managing stress and speeding up recovery is a new evolution for Pulsetto’s technology. That’s why ScaleWolf has invested €2 million in Pulsetto, a Lithuanian startup backed by Kilo Health, developing vagus nerve stimulation technology. This funding will help adapt innovation for military use, providing a new tool to support resilience in high-pressure environments.
WALLESS is proud to have advised ScaleWolf on this deal. Well done to our team – Partner expert Artūras Grimaila, Associate Ieva Pikaitė, and congratulations to everyone involved!